Credit Agreements in the Pharmaceuticals Industry
350 Contracts & Agreements
- Acer Therapeutics Inc. (7 contracts)
- Acreage Holdings, Inc. (8)
- Adamis Pharmaceuticals Corp (3)
- AERIE PHARMACEUTICALS INC (1)
- AGILE THERAPEUTICS INC (16)
- Akorn (21)
- Allergan, plc (2)
- Altus Pharmaceuticals Inc. (1)
- Amag Pharmaceuticals (1)
- Amneal Pharmaceuticals, Inc. (2)
- Amphastar Pharma (6)
- ANGIOTECH PHARMACEUTICALS INC (6)
- Anthera Pharmaceuticals Inc (1)
- APP Pharmaceuticals, Inc. (2)
- APRICUS BIOSCIENCES, INC. (1)
- Aquestive Therapeutics, Inc. (4)
- Aralez Pharmaceuticals Inc. (2)
- ARIAD PHARMACEUTICALS INC (7)
- AVALON PHARMACEUTICALS INC (1)
- AVENUE THERAPEUTICS, INC. (1)
- Axsome Therapeutics, Inc. (1)
- AYTU BIOSCIENCE, INC (1)
- BARR PHARMACEUTICALS INC (6)
- Baudax Bio, Inc. (7)
- Bausch Health Companies Inc. (10)
- BIODELIVERY SCIENCES INTERNATIONAL INC (2)
- Biofrontera Inc. (1)
- BioPharmX Corp (1)
- BODY & MIND INC. (2)
- Bohai Pharmaceuticals Group, Inc. (1)
- BRADLEY PHARMACEUTICALS INC (1)
- Bright Green Corp (3)
- Bristol-Myers Squibb (24)
- Catalent Inc (5)
- CELGENE CORP (4)
- Cerecor Inc. (2)
- Endo International plc (2)
- Eton Pharmaceuticals, Inc. (3)
- EyePoint Pharmaceuticals, Inc. (1)
- Foamix Pharmaceuticals Ltd. (4)
- Fresenius Kabi Pharmaceuticals Holding, Inc. (3)
- GUILFORD PHARMACEUTICALS INC (1)
- Harmony Biosciences Holdings, Inc. (1)
- Haymaker Acquisition Corp. III (1)
- Horizon Pharma plc (1)
- iANTHUS CAPITAL HOLDINGS, INC. (1)
- Jaguar Health, Inc. (3)
- Jazz Pharmaceuticals plc (2)
- Kaleido Biosciences, Inc. (2)
- Kedem Pharmaceuticals Inc. (1)
- KID CASTLE EDUCATIONAL CORP (1)
- KOS PHARMACEUTICALS INC (2)
- Lannett Company, Inc. (4)
- Liquidia Corp (2)
- Mallinckrodt (1)
- MARINUS PHARMACEUTICALS INC (1)
- Medicine Man Technologies, Inc. (1)
- MedMen Enterprises, Inc. (1)
- Menlo Therapeutics Inc. (5)
- Merck (1)
- MiddleBrook Pharmaceuticals, Inc. (1)
- Molecular Insight Pharmaceuticals, Inc. (1)
- Mylan N.V. (17)
- Neos Therapeutics, Inc. (2)
- NEW RIVER PHARMACEUTICALS INC (1)
- NOVEN PHARMACEUTICALS INC (2)
- OCULAR THERAPEUTIX, INC (10)
- OptiNose, Inc. (6)
- PENWEST PHARMACEUTICALS CO (1)
- Perrigo (3)
- Pfizer (2)
- Phibro Animal Health Corporation (7)
- Prestige Brands Holdings Inc (1)
- Processa Pharmaceuticals, Inc. (4)
- Recro Pharma, Inc. (16)
- Reliant Pharmaceuticals, Inc. (3)
- Royalty Pharma plc (2)
- Sagent Pharmaceuticals, Inc. (11)
- SALIX PHARMACEUTICALS LTD (2)
- SANCILIO PHARMACEUTICALS COMPANY, INC. (3)
- scPharmaceuticals Inc. (1)
- SIGA TECHNOLOGIES INC (3)
- Supernus Pharmaceuticals, Inc. (1)
- TerrAscend Corp. (4)
- TEVA PHARMACEUTICAL INDUSTRIES LTD (3)
- TherapeuticsMD, Inc. (2)
- Tilray, Inc. (10)
- Tribute Pharmaceuticals Canada Inc. (1)
- Upjohn Inc (2)
- VALEANT PHARMACEUTICALS INTERNATIONAL (1)
- Valera Pharmaceuticals Inc (1)
- Verrica Pharmaceuticals Inc. (2)
- Vireo Health International, Inc. (6)
- Zoetis (7)
- Zomedica Pharmaceuticals Corp. (2)
- Amended and Restated Credit Agreement, dated as of March 14, 2024, by and among Aphria Diamond Inc., Aphria Inc., the Company, Bank of Montreal and the Guarantors and Lenders... (Tilray, Inc., Filed With SEC on April 9, 2024)
- Third Amendment and Consent to Credit Agreement, dated as of March 29, 2024, by and among American Beverage Crafts Group, Inc. (formerly known as Four Twenty Corporation), Bank of... (Tilray, Inc., Filed With SEC on April 9, 2024)
- Waiver to Credit Agreement, dated as of January 5, 2024, by and between Four Twenty Corporation, Bank of America, N.A., and the Guarantors and Lenders party thereto (incorporated... (Tilray, Inc., Filed With SEC on April 9, 2024)
- Credit Agreement dated March 14, 2024 (Bright Green Corp, Filed With SEC on March 19, 2024)
- Second Amendment to Credit Agreement, dated as of January 31, 2024, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Verrica Pharmaceuticals Inc., Filed With SEC on February 29, 2024)
- First Amendment to Credit Agreement, dated as of December 20, 2023, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Verrica Pharmaceuticals Inc., Filed With SEC on February 29, 2024)
- Eighth Amendment to Credit Agreement and Guaranty, by and among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (AGILE THERAPEUTICS INC, Filed With SEC on February 15, 2024)
- Waiver to Credit Agreement, dated as of January 5, 2024, by and between Four Twenty Corporation, Bank of America, N.A., and the Guarantors and Lenders party thereto (Tilray, Inc., Filed With SEC on January 9, 2024)
- Amended and Restated Revolving Credit Agreement, dated as of September 15, 2021, as amended by Amendment No. 1, dated as of October 31, 2022, as amended by Amendment No. 2, dated... (Royalty Pharma plc, Filed With SEC on December 27, 2023)
- Seventh Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party thereto and... (AGILE THERAPEUTICS INC, Filed With SEC on December 11, 2023)
- Amendment to Warrants and Certificate of Adjustment between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of October 30, 2023 (AGILE THERAPEUTICS INC, Filed With SEC on December 11, 2023)
- Amendment No. 10 to Amended and Restated Credit Agreement, dated as of November 22, 2023, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JPMorgan... (Catalent Inc, Filed With SEC on November 27, 2023)
- Form of DIP Credit Agreement, to be entered intoby the Company, Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO USHolding, Inc (BioPharmX Corp, Filed With SEC on November 17, 2023)
- Convertible Credit Facility Agreement by and among NMG IL 4, LLC and DEP Nevada, Inc., dated December 26, 2019 (BODY & MIND INC., Filed With SEC on November 14, 2023)
- Convertible Credit Facility Agreement by and among NMG IL 1, LLC and DEP Nevada, Inc., dated December 26, 2019 (BODY & MIND INC., Filed With SEC on November 14, 2023)
- Credit and Security Agreement, dated August 2, 2023, by and among Barings Finance LLC, as administrative agent, the Registrant, and the Lenders listed therein (OCULAR THERAPEUTIX, INC, Filed With SEC on November 7, 2023)
- Second Amendment and Consent to Credit Agreement, dated as of September 29, 2023 (Tilray, Inc., Filed With SEC on October 2, 2023)
- Amendment No. 9 to Amended and Restated Credit Agreement, dated as of September 27, 2023, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JPMorgan... (Catalent Inc, Filed With SEC on September 28, 2023)
- Payoff Letter, dated as of September 22, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I, LLC, Powerscourt... (Cerecor Inc., Filed With SEC on September 26, 2023)
- Amendment No. 7 to Credit Agreement, dated as of August 31, 2023, by and among Baudax Bio, Baudax Bio N.A. LLC, Baudax Bio Limited and TeraImmune, LLC, the lenders party thereto... (Baudax Bio, Inc., Filed With SEC on September 5, 2023)
- Second Forbearance Agreement, dated as of August 14, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I, LLC,... (Cerecor Inc., Filed With SEC on August 14, 2023)
- Joinder, Third Amendment to Credit Agreement and Security Agreements and Consent, dated as of June 9, 2023, among WDB Holding MI, Inc., Gage Growth Corp., Gage Innovations Corp.,... (TerrAscend Corp., Filed With SEC on August 10, 2023)
- Sixth Amendment to Credit Agreement, dated June 22, 2023 by and among WDB Holding PA, Inc., the lenders party thereto and Acquiom Agency Services LLC as Administrative Agent (TerrAscend Corp., Filed With SEC on August 10, 2023)
- Fifth Amendment to Credit Agreement, dated April 14, 2023 by and among WDB Holding PA, Inc., the lenders party thereto and Acquiom Agency Services LLC as Administrative Agent (TerrAscend Corp., Filed With SEC on August 10, 2023)
- Conforming Changes Amendment, dated as of June 7, 2023, entered into by Bank of America, N.A. as administrative agent to Credit Agreement, dated as of May 5, 2021, by and among... (Jazz Pharmaceuticals plc, Filed With SEC on August 9, 2023)
- Amendment No. 2 to Fourth Amended and Restated Credit and Security Agreement, dated May 4, 2023, by and among MidCap Financial Trust, as administrative agent, the Registrant, and... (OCULAR THERAPEUTIX, INC, Filed With SEC on August 7, 2023)
- Sixth Amendment to Credit Agreement and First Amendment to Security Agreement, dated as of March 31, 2023, by and among Goodness Growth Holdings, Inc. and certain of its... (Vireo Health International, Inc., Filed With SEC on August 4, 2023)
- Amendment No. 1 to Forbearance Agreement and Amendment No. 6 to Credit Agreement, dated as of July 30, 2023, by and among Baudax Bio, Baudax Bio N.A. LLC, Baudax Bio Limited and... (Baudax Bio, Inc., Filed With SEC on July 31, 2023)
- Credit and Security Agreement, dated June 30, 2023, by and among Bausch Receivables Funding LP, as Borrower, Bausch Receivables Funding GP ULC, Bausch Health US, LLC, as the... (Bausch Health Companies Inc., Filed With SEC on July 7, 2023)
- Form of Warrant to Purchase Subordinate Voting Shares of Goodness Growth Holdings, Inc.(issued in conjunction with Fifth Amendment to Credit Agreement and First Amendment to... (Vireo Health International, Inc., Filed With SEC on May 15, 2023)
- Commitment Letter dated as of March 9, 2023 between the Company and MidCap Business Credit LLC (Biofrontera Inc., Filed With SEC on May 12, 2023)
- Amendment No. 1 to Fourth Amended and Restated Credit and Security Agreement, dated March 31, 2023, by and among MidCap Financial Trust, as administrative agent, the Registrant,... (OCULAR THERAPEUTIX, INC, Filed With SEC on May 8, 2023)
- Second Amendment to Credit Agreement, dated April 28, 2023, by and among High Street Capital Partners, LLC, Acreage Holdings, Inc., each lender identified on the signature pages... (Acreage Holdings, Inc., Filed With SEC on May 4, 2023)
- Waiver and Sixth Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (AGILE THERAPEUTICS INC, Filed With SEC on April 14, 2023)
- Amendment No. 5 to Credit Agreement, dated March 29, 2023, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the... (Baudax Bio, Inc., Filed With SEC on March 31, 2023)
- Fourth Amendment to Credit Agreement, dated March 2, 2022, by and among Goodness Growth Holdings, Inc., and certain of its subsidiaries, the persons from time-to-time party... (Vireo Health International, Inc., Filed With SEC on March 31, 2023)
- Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of March 21, 2023 (AGILE THERAPEUTICS INC, Filed With SEC on March 23, 2023)
- Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of March 21, 2023 (AGILE THERAPEUTICS INC, Filed With SEC on March 23, 2023)
- Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of March 21, 2023 (AGILE THERAPEUTICS INC, Filed With SEC on March 23, 2023)
- Exhibit 10.1 Credit Line Agreement between UBS Bank USA and Supernus Pharmaceuticals, Inc. dated as of February 8, 2023 (Supernus Pharmaceuticals, Inc., Filed With SEC on February 14, 2023)
